Fludarabine
Adult Acute Lymphoblastic Leukemia in Remission
Northside Hospital, Inc.Small moleculePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 65/ 100
- Competitive Position
- 89/ 100
Competitive context
73 Active assets in the Adult Acute Lymphoblastic Leukemia in Remission cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MERCAPTOPURINE ANHYDROUS Shanxi Bethune Hospital | Phase 4 | A |
Cytosin-Arabinosid PETHEMA Foundation | Phase 4 | BBB |
METHOTREXATE PETHEMA Foundation | Phase 4 | BBB |
Cyclophosphamide The First Affiliated Hospital of Zhengzhou University | Phase 4 | BBB |
DEXAMETHASONE Shanxi Bethune Hospital | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →